Sep 30, 2026 07:20AM
Sep 29, 2026 07:03AM
Sep 29, 2026 07:00AM
Jun 9, 2026 08:30PM
Jun 9, 2026 08:30PM
Mar 18, 2026 10:03AM
Mar 18, 2026 06:33AM H.C. Wainwright Downgrades Aldeyra Therapeutics (ALDX) to Neutral
Mar 17, 2026 04:08PM
Mar 17, 2026 02:45PM
Mar 17, 2026 08:30AM
Mar 17, 2026 08:30AM
Dec 16, 2025 03:57AM
Dec 15, 2025 07:30PM
Nov 13, 2025 07:00AM Aldeyra expands RASP platform to neurological diseases
Nov 13, 2025 07:00AM
Oct 28, 2025 07:01AM
Oct 28, 2025 07:01AM
Oct 8, 2025 12:58PM
Aug 28, 2025 07:02AM
Aug 28, 2025 07:01AM
Aug 19, 2025 07:01AM Aldeyra receives fast track status for retinitis pigmentosa drug
Aug 19, 2025 07:01AM
Aug 8, 2025 12:20PM
Jul 24, 2025 07:01AM
Jul 24, 2025 07:00AM
Jul 17, 2025 07:02AM
Jul 17, 2025 07:00AM
Jun 26, 2025 08:18AM Jones Trading Reiterates Buy Rating on Aldeyra Therapeutics (ALDX)
Jun 26, 2025 07:00AM
Jun 26, 2025 07:00AM
Jun 18, 2025 03:02PM
Jun 17, 2025 07:02AM
Jun 17, 2025 07:00AM
May 18, 2025 10:00AM
May 13, 2025 01:22PM INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Aldeyra Therapeutics, Inc. – ALDX
May 9, 2025 08:00AM
May 6, 2025 07:08AM
May 5, 2025 06:34PM
May 5, 2025 02:12PM
May 4, 2025 08:18AM
May 2, 2025 03:33PM
May 1, 2025 03:18PM ALDX INVESTIGATION NOTICE: Aldeyra Therapeutics, Inc. Investors are Notified of the Ongoing Securities Investigation
Apr 30, 2025 07:36AM
Apr 29, 2025 11:16AM
Apr 28, 2025 07:11AM
Apr 26, 2025 07:08AM
Apr 25, 2025 12:57PM
Apr 24, 2025 07:36AM
Apr 22, 2025 07:17AM ALDX LEGAL UPDATE: Aldeyra Therapeutics, Inc. Investors are Notified that the Company is being Investigated for Securities Violations and to Contact BFA Law
Apr 21, 2025 02:30PM

334,271 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All